Nasdaq

Matinas BioPharma Holdings, Inc. Secures $3.3 Million in Financing and Appoints Dr. Robin L. Smith to Board of Directors

Matinas BioPharma secures $3.3 million from investors, appoints Dr. Robin L. Smith to its Board amid strategic initiatives. Matinas BioPharma Holdings, Inc. announced a securities purchase agreement ...
Seeking Alpha

Matinas BioPharma Announces Agreement for the Acquisition of Preferred Stock and Appointment of Dr. Robin L. Smith to the Board of Directors

BEDMINSTER, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma (MTNB) Holdings, Inc. (NYSE American: MTNB) (the “Company”) today announced that the Company entered into a securities purchase ...
Fox 5 San Diego

BioFlex Appoints Renowned Healthcare Leader Dr. Robin L. Smith to Advisory Board

PHOENIX, AZ, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- BioFlex, a pioneering insurance solutions provider at the intersection of healthcare and technology ...